Brain Research Unit (BRU) - Clinical Trial Unit

BRU is a neurological clinical trial unit providing services for our academic and industry collaborators

• Our mission is to reduce the burden of neurological disease
• Our primary area of know-how is clinical research, clinical drug trials, diagnostics, prevention and treatment of neurodegenerative and cerebrovascular disorders and biomarker research
• BRU is committed to conducting high quality research in clinical science and in drug development in collaboration with local, national, international research groups and pharmaceutical industry
• BRU is located on the campus of University of Eastern Finland, within a stone’s throw distance from the Kuopio University Hospital and 2 km from a town center

BRU has extensive experience in

• studying the mechanisms of drugs in various model systems
• studying the genetics and risk factors of complex diseases in large population-based cohorts
• developing biomarkers for neurodegenerative diseases
• conducting early phase IIa trials as well as phase III-IV multi-center studies as a clinical study site according to GCP guidelines
• research together with clinical trials are performed efficiently within the allotted time framework

Clinical trial professional team

• is dedicated team with professionals: investigators, study nurses, neuropsychologists and other research personnel needed for conducting of studies
• has experience in conducting clinical trials since 1992
• adheres to GCP and to the ethical principles
• takes good care of safety and well-being of study subjects and their caregivers
• has the capacity to recruit trial subjects within agreed timelines
• is well recognized team having worldwide collaboration network

Study recruitment

• BRU has excellent facilities and the location is ideal for subject recruitment
• The catchment area of Kuopio University Hospital has about 247 000 inhabitants
• The research-friendly attitude of our population provide good prerequisites for clinical research
• Treatment compliance and commitment to the studies are excellent